Studies have demonstrated that mutations or amplifications in PIKC3CA, mutations in PIK3R, loss of PTEN, and mutations or amplifications in AKT isoforms cause uncontrolled activation of this pathway and ovarian cancer formation [109]. This evidence concerns the gene AKT1 and ovarian carcinoma.